The Aurum Institute

The Aurum Institute is a leading African health organisation advancing the prevention, treatment, and care of HIV and tuberculosis (TB). Headquartered in South Africa, Aurum works at the intersection of science, policy, and service delivery to improve health outcomes for people and communities living in vulnerable and resource-constrained settings.

With one of the world’s largest HIV programmes and a globally recognised TB research portfolio, Aurum combines innovation in global health research with health systems strengthening and large-scale programme implementation. Its work spans a diverse range of activities, including:

• Implementation and technical support for HIV and TB prevention, care, and treatment across South Africa’s public health system
• Cutting-edge clinical research on HIV prevention
• TB and HIV vaccine trials
• Large-scale TB prevention and screening initiatives

Committed to strengthening the sustainability of its global health and medical activities for vulnerable populations, often the most impacted by climate change, Aurum has recently joined the Accelerator to reduce its environmental impact, accelerating its transition to a low greenhouse gas emissions organisation and strengthening its resilience.

The organisation’s commitments include reducing its greenhouse gas emissions by 60% by 2035 in line with the Paris Agreement, and reporting publicly, annually and transparently on its greenhouse gas emissions measurements and reduction progress.